期刊文献+

阻塞性睡眠呼吸暂停会增加某些癌症的患病率和病死率 被引量:4

Obstructive sleep apnea can increase the morbidity and mortality of certain cancer
原文传递
导出
摘要 阻塞性睡眠呼吸暂停是一种全身性疾病,能够引起心、脑等多脏器损害,近年来的研究发现,阻塞性睡眠呼吸暂停可增加肺癌、乳腺癌等某些癌症的患病率和病死率,严重危害到人类的健康。因为阻塞性睡眠呼吸暂停是一种可以治疗的疾病,所以我们应该对阻塞性睡眠呼吸暂停与癌症的关系进行更深一步的研究,从而降低癌症的发生率,提高人们的生活质量。 Obstructive sleep apnea (OSA) is a systemic disease which can causes multiple organ damage such as heart and brain. Researches in recent years found that OSA can increase the morbidity and mortality of certain cancer such as lung cancer and breast cancer. OSA is dangerous for health. As OSA is a treatable disease,in order to reduce the incidence of cancer and enhance people's quality of life, further study will be needed to figure out the relationship between OSA and cancer.
出处 《国际呼吸杂志》 2014年第11期853-855,共3页 International Journal of Respiration
关键词 睡眠呼吸暂停 阻塞性 癌症 患病率 病死率 Sleep apnea Obstructive Cancer Morbidity Mortality
  • 相关文献

参考文献14

  • 1袁雅冬,于婧,邓华君.2011年呼吸病学研究进展[J].临床荟萃,2012,27(7):553-558. 被引量:14
  • 2Almendros I, Montserrat JM, Ramirez J, et al. Intermittent hypoxia enhances Cancer progression in a mouse model of sleep apnoea[J]. Eur Respir J, 2012,39:215-217.
  • 3Nieto FJ, Peppard PE, Young T, et al. Sleep-disordered Breathing and Cancer Mortality Results from the Wisconsin Sleep Cohort Study[J]. Am J Rsspir Crit Care Med, 2012, 186:190-194.
  • 4Almendros I, Montserrat JM, Torres M, et al. Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea[J]. Respir Physiol Neurobiol, 2013,186:303-307.
  • 5Kakizaki M,Kuriyama S,Sone T,et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study[J]. Br J Cancer, 2008,99 : 1502- 1505.
  • 6Verkasalo PK, Lillberg K, Stevens RG, et al. Sleep duration and breast cancer:a prospective cohort study[J]. Cancer Res, 2005,65 : 9595-600.
  • 7Wu AH, Wang R, Koh WP, et al. Sleep duration, melatonin and breast Cancer among Chinese women in Singapore[J]. Carcinogenesis, 2008,29 : 1244-1248.
  • 8yon Ruesten A, Weikert C, Fietze I, et al. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study[J]. PLoS One, 2012,7 : e30972.
  • 9Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and Cancer incidence in a large multieenter Spanish cohort [J]. Am J Respir Crit Care Med,2013,187:99-105.
  • 10Reuter S,Gupta SC, Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: how are they linked[J].? Free Radio Biol Med,2010,49:1603-1616.

二级参考文献23

  • 1Nussbaumer-Ochsner Y,Rabe KF.Systemic manifestations ofCOPD[J].Chest,2011,139(1):165-173.
  • 2Markoulaki D,Kostikas K,Papatheodorou G,et al.Hemoglobin,erthropoietin and systemic inflammation inexacerbations of COPD[J].Eur J Intern Med,2011,22(1):103-107.
  • 3Cerveri I,Brusasco V.Revisited role for mucus hypersecretionin the pathogenesis of COPD[J].Eur Respir Rev,2010,19(116):109-112.
  • 4Poole P,Black PN.Mucolytic agents for chronic bronchitis orchronic obstructive pulmonary disease[J].Cochrane DatabaseSyst Rev,2010,17(2):CD001287.
  • 5Raghu G,Collard HR,Egan JJ,et al.An official ATS/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J].Am JRespir Crit Care Med,2011,183(6):788-824.
  • 6Daniels CE,Lasky JA,Limper AH,et al.Imatinib treatmentfor idiopathic pulmonary fibrosis:randomized placebo-controlled trial results[J].Am J Respir Crit Care Med,2010,181(6):604-610.
  • 7Kris MG,Johnson BE,Kwiatkowski DJ,et al.Identification ofdriver mutation in tumor sprcimens from 1000patients withlung ahenocarcinoma:The NCI’s Lung Cancer MutationConsortium(LCMC)[C].ASCO,2011:CRA7506.
  • 8Sivachenko A,Hammerman P,Pho N,et al.Genomiccharacterization and targeted therapeutics in squamous celllung cancer[C].WCLC,2011:PRS1.
  • 9Hirashima T,Okamoto I,Yoshioka H,et al.PhaseⅢstudycomparing the effects of carboplatin plus S-1and carboplatinplus paclitaxel in chemotheray-nave patients with advancenon-small cell lung cancer:An updated report of the LETSstudy(WJTOG3605)[J].J Clin Oncol,2011,29(Suppl):abstr7552.
  • 10Zhou C,Wu YL,Chen G,et al.Updated efficacy and quality-of-life(QoL)analyses in OPTIMAL,aphaseⅢrandomized,open-label study of first-line erlotinib versus gemcitabine/carboplatin in patients with EGFR-activating mutation-positive(EGFR Act Mut_)advanced non-small cell lung cancer(NSCLC)[J].J Clin Oncol,2011,29(Suppl):abstr 7520.

共引文献13

同被引文献51

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部